ENB Therapeutics’ Orphan Drug, Endothelin Receptor Type B Target for Resistant Cancers February 15, 2023
2 Women-Founded Companies are Optimizing Targeted Lipid Nanoparticle mRNA Therapies for a Rare Respiratory DiseaseFebruary 3, 2023
Feature Stories A New Lymphoid Technology That Accelerates Immune Reconstitution in Hematopoietic Stem Cell TransplantationBy Radhika ShahDecember 24, 2022Smart Immune is a clinical-stage biotechnology startup headquartered in France, developing a thymus-empowered T-cell therapy platform called ProTcell Platform. The… Read More
